ENDRA Life Sciences (NDRA) Preferred Shares (2020 - 2023)

ENDRA Life Sciences has disclosed Preferred Shares across 4 years of filings, most recently posting $1.0 for Q1 2023.

• In Q1 2023, Preferred Shares changed N/A year-over-year to $1.0; the TTM figure through Mar 2023 stood at $1.0 (changed N/A YoY), while the FY2020 annual figure was $1.0, changed N/A from the prior year.
• Preferred Shares was little changed at $1.0 in Q1 2023, from $1.0 in the prior quarter.
• Over the last five years, Preferred Shares for NDRA reached as high as $1.0 in Q1 2020 and fell as low as $1.0 in Q1 2020.
• The 4-year median for Preferred Shares is $1.0 (2020), against an average of $1.0.
• The widest YoY moves for Preferred Shares: up 0.0% in 2021, down 0.0% in 2021.
• A 4-year view of Preferred Shares shows it stood at $1.0 in 2020, then changed by 0.0% to $1.0 in 2021, then changed by 0.0% to $1.0 in 2022, then changed by 0.0% to $1.0 in 2023.
• According to Business Quant data, Preferred Shares over the past three periods registered $1.0, $1.0, and $1.0 for Q1 2023, Q3 2022, and Q2 2022 respectively.